# Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women

> **NCT04418388** · PHASE1 · COMPLETED · sponsor: **Pharmbio Korea Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** PBK-1801
- **DRUG:** PBK-1801
- **DRUG:** PBK-1801

## Key facts

- **NCT ID:** NCT04418388
- **Lead sponsor:** Pharmbio Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-24
- **Primary completion:** 2019-12-03
- **Final completion:** 2019-12-23
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04418388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04418388, "Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04418388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*